$3.32 - $7.65 BILLION Market Size
The $3.32 – $7.65 BILLION dollar cancer diagnostic market usually reserved for institutional and large investors. Your investment gives you a piece of the Medical Technology industry.
The Future of Prostate Disease Diagnosis
ProstaMetrix is a portable, physician’s office medical tech device that turns a digital rectal exam into a next generation cancer screening tool. The ProstaMetrix device makes it possible to treat multiple forms of prostate disorder and diseases in a low-cost, point-of-care and real-time procedure
2nd leading cause of cancer death in men in the US
One in eight men will be diagnosed with prostate cancer, over 33,330 will die in the US alone
The future of Prostate Disease Management. Our goal is provide the tools to diagnose Prostate Cancer and Prostate Disease EARLIER – leading to a better chance of treatment. Your investment helps us get there.